Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational study examines the link between psoriasis severity and comorbidity index, highlighting implications for biologic therapy.

Higher psoriasis severity correlates with increased comorbidity burden, impacting treatment choices.
The Charlson Comorbidity Index provides crucial metrics, suggesting that comorbidities influence patient management.
Multicenter observational study reveals insights into patient outcomes with biologic therapy across diverse populations.
Understanding comorbidities in psoriasis patients may improve the effectiveness of biologic treatments.

Bernardini et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark